Exosomal miR-34b inhibits proliferation and the epithelial-mesenchymal transition by targeting Notch2 in ovarian cancer

Exosomal microRNA (miR) can affect signaling pathways in various physiological and pathological conditions, including ovarian cancer (OC). miR-34b, the first microRNA targeted in a human clinical trial for cancer treatment, exhibited decreased expression in several cancer types. However, the biologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Shenglian, Liu, Wuxia, Shi, Hong, Zhou, Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400462/
https://www.ncbi.nlm.nih.gov/pubmed/32782588
http://dx.doi.org/10.3892/ol.2020.11837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400462/
https://www.ncbi.nlm.nih.gov/pubmed/32782588
http://dx.doi.org/10.3892/ol.2020.11837

Ejemplares similares